Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Saito Chihiro | Nov 18, 2024 | Sell | 2,258 | $2.12 | $4,800 |
| Tingley Whittemore | Aug 16, 2024 | Sell | 5,803 | $2.8945 | $17,000 |
| Tingley Whittemore | Aug 16, 2024 | Sell | 1,625 | $2.8945 | $4,700 |
| Ali Faraz | Aug 16, 2024 | Sell | 5,802 | $2.8945 | $17,000 |
| Ali Faraz | Aug 16, 2024 | Sell | 3,946 | $2.8945 | $11,000 |
| Saito Chihiro | Aug 16, 2024 | Sell | 902 | $2.8945 | $2,600 |
| Saito Chihiro | Aug 16, 2024 | Sell | 807 | $2.8945 | $2,300 |
| Saito Chihiro | Aug 16, 2024 | Sell | 654 | $2.8945 | $1,900 |
| Hoey Timothy | Mar 5, 2024 | Sell | 3,300 | $7.0003 | $23,000 |
| Hoey Timothy | Feb 20, 2024 | Sell | 6,369 | $5.309 | $34,000 |
| Hoey Timothy | Feb 20, 2024 | Sell | 200 | $6.165 | $1,200 |
| Hoey Timothy | Feb 16, 2024 | Sell | 4,681 | $5.86 | $27,000 |
| Tingley Whittemore | Feb 16, 2024 | Sell | 6,500 | $5.86 | $38,000 |
| PATTERSON LEONE D | Feb 16, 2024 | Sell | 5,201 | $5.86 | $30,000 |
| Ali Faraz | Feb 16, 2024 | Sell | 6,358 | $5.86 | $37,000 |
| COLUMN GROUP III-A, LP | Feb 12, 2024 | Buy | 2,222,222 | $4.5 | $10M |
| GOEDDEL DAVID V | Feb 12, 2024 | Buy | 2,222,222 | $4.5 | $10M |
| Hoey Timothy | Aug 29, 2023 | Sell | 7,243 | $4.26 | $31,000 |
| Hoey Timothy | Aug 16, 2023 | Sell | 4,007 | $3.81 | $15,000 |
| Tingley Whittemore | Aug 16, 2023 | Sell | 5,563 | $3.81 | $21,000 |
| PATTERSON LEONE D | Aug 16, 2023 | Sell | 4,452 | $3.81 | $17,000 |
| Ali Faraz | Aug 16, 2023 | Sell | 5,563 | $3.81 | $21,000 |
| COLUMN GROUP III-A, LP | Mar 10, 2023 | Buy | 6,779 | $2.5956 | $18,000 |
| GOEDDEL DAVID V | Mar 10, 2023 | Buy | 6,779 | $2.5956 | $18,000 |
| COLUMN GROUP III-A, LP | Feb 8, 2023 | Buy | 1,500,000 | $2.6 | $3.9M |
| GOEDDEL DAVID V | Feb 8, 2023 | Buy | 1,500,000 | $2.6 | $3.9M |
| COLUMN GROUP III-A, LP | Jan 19, 2023 | Buy | 69,739 | $2.4979 | $170,000 |
| GOEDDEL DAVID V | Jan 19, 2023 | Buy | 69,739 | $2.4979 | $170,000 |
| COLUMN GROUP III-A, LP | Jan 18, 2023 | Buy | 135,688 | $2.5163 | $340,000 |
| GOEDDEL DAVID V | Jan 18, 2023 | Buy | 135,688 | $2.5163 | $340,000 |
| COLUMN GROUP III-A, LP | Jan 17, 2023 | Buy | 49,463 | $2.4947 | $120,000 |
| GOEDDEL DAVID V | Jan 17, 2023 | Buy | 49,463 | $2.4947 | $120,000 |
What's the latest insider transaction for Tenaya Therapeutics?
The most recent insider transaction for Tenaya Therapeutics was conducted by Saito Chihiro, who sold 2,258 shares on November 18, 2024 at a price of $2.12 per share.
Which insider bought the most TNYA stock over the last two years?
GOEDDEL DAVID V has bought the most TNYA stock in the last 2 years, with a total value of $15M.
Which insider has sold the most TNYA stock over the last two years?
Hoey Timothy has sold the most TNYA stock in the last 2 years, with a total value of $130,000.
What is the total value of insider transactions for Tenaya Therapeutics (TNYA) in the last 2 years?
According to our estimates, the total value of insider transactions for Tenaya Therapeutics in the last 2 years is positive, amounting to $29M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Tenaya Therapeutics' market confidence?
Over the last 2 years, insider transactions for Tenaya Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
